H. H. Kazan Et Al. , "15-LOX-1 has diverse roles in the resensitization of resistant cancer cell lines to doxorubicin," JOURNAL OF CELLULAR PHYSIOLOGY , vol.235, no.5, pp.4965-4978, 2020
Kazan, H. H. Et Al. 2020. 15-LOX-1 has diverse roles in the resensitization of resistant cancer cell lines to doxorubicin. JOURNAL OF CELLULAR PHYSIOLOGY , vol.235, no.5 , 4965-4978.
Kazan, H. H., Urfali-Mamatoglu, C., Yalcin, G. D., Bulut, O., Sezer, A., Banerjee, S., ... Gündüz, U.(2020). 15-LOX-1 has diverse roles in the resensitization of resistant cancer cell lines to doxorubicin. JOURNAL OF CELLULAR PHYSIOLOGY , vol.235, no.5, 4965-4978.
Kazan, Hasan Et Al. "15-LOX-1 has diverse roles in the resensitization of resistant cancer cell lines to doxorubicin," JOURNAL OF CELLULAR PHYSIOLOGY , vol.235, no.5, 4965-4978, 2020
Kazan, Hasan H. Et Al. "15-LOX-1 has diverse roles in the resensitization of resistant cancer cell lines to doxorubicin." JOURNAL OF CELLULAR PHYSIOLOGY , vol.235, no.5, pp.4965-4978, 2020
Kazan, H. H. Et Al. (2020) . "15-LOX-1 has diverse roles in the resensitization of resistant cancer cell lines to doxorubicin." JOURNAL OF CELLULAR PHYSIOLOGY , vol.235, no.5, pp.4965-4978.
@article{article, author={Hasan Huseyin Kazan Et Al. }, title={15-LOX-1 has diverse roles in the resensitization of resistant cancer cell lines to doxorubicin}, journal={JOURNAL OF CELLULAR PHYSIOLOGY}, year=2020, pages={4965-4978} }